2nd coronavirus vaccine shows early success in U.S. trial


For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the United States and around the world.

Moderna said its vaccine appears to be 94.5 per cent effective, according to preliminary data from the company’s still-ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.

More to come.

Read more at CBC.ca